The Political Component of COVID-19 Vaccine Choice: Results from a Conjoint Experiment

Overview

Journal Public Health

Publisher Elsevier

Specialty Public Health

Date 2023 Feb 27

PMID 36848795

Authors

Zs Papp

G B Nkansah

Affiliations

Soon will be listed here.

Abstract

Objectives: Prior research highlights the role of efficacy, vaccine safety, and availability in vaccine hesitancy. Research is needed to better understand the political driving forces behind COVID-19 vaccine uptake. We examine the effects of the origin of a vaccine, and approval status within the EU on vaccine choice. We also test if these effects differ by party affiliation among Hungarians.

Study Design: We use a conjoint experimental design to assess multiple causal relationships. Respondents choose between two hypothetical vaccine profiles randomly generated from 10 attributes. The data were gathered from an online panel in September 2022. We applied a quota for vaccination status and party preference. Three hundred twenty-four respondents evaluated 3888 randomly generated vaccine profiles.

Methods: We analyse the data using an OLS estimator with standard errors clustered by respondents. To further nuance our results, we test for task, profile, and treatment heterogeneity effects.

Results: By origin, respondents prefer German (MM 0.55; 95% CI 0.52-0.58) and Hungarian (0.55; 0.52-0.59) vaccines over US (0.49; 0.45-0.52) and Chinese vaccines (0.44; 0.41-0.47). By approval status, vaccines approved by the EU (0.55, 0.52-0.57) or pending authorization (0.5, 0.48-0.53) are preferred over unauthorised ones (0.45, 0.43-0.47). Both effects are conditional on party affiliation. Government voters especially prefer Hungarian vaccines (0.6; 0.55-0.65) over others.

Conclusions: The complexity of vaccination decisions calls for the usage of information shortcuts. Our findings demonstrate a strong political component that motivates vaccine choice. We demonstrate that politics and ideology have broken into fields of individual-level decisions such as health.

References

Wong L, Alias H, Wong P, Lee H, AbuBakar S . The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother. 2020; 16(9):2204-2214. PMC: 7553708. DOI: 10.1080/21645515.2020.1790279. View

Motta M . Can a COVID-19 vaccine live up to Americans' expectations? A conjoint analysis of how vaccine characteristics influence vaccination intentions. Soc Sci Med. 2021; 272:113642. PMC: 7832269. DOI: 10.1016/j.socscimed.2020.113642. View

Goodwin R, Nguyen Luu L, Wiwattanapantuwong J, Kovacs M, Suttiwan P, Levin Y . Two-Tailed Dogs, Social Unrest and COVID-19 Vaccination: Politics, Hesitancy and Vaccine Choice in Hungary and Thailand. Vaccines (Basel). 2022; 10(5). PMC: 9147869. DOI: 10.3390/vaccines10050789. View

Chaudhary F, Ahmad B, Khalid M, Fazal A, Javaid M, Butt D . Factors influencing COVID-19 vaccine hesitancy and acceptance among the Pakistani population. Hum Vaccin Immunother. 2021; 17(10):3365-3370. PMC: 8437474. DOI: 10.1080/21645515.2021.1944743. View

MacDonald N . Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015; 33(34):4161-4. DOI: 10.1016/j.vaccine.2015.04.036. View

Dube E, MacDonald N . How can a global pandemic affect vaccine hesitancy?. Expert Rev Vaccines. 2020; 19(10):899-901. DOI: 10.1080/14760584.2020.1825944. View

Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C . A global database of COVID-19 vaccinations. Nat Hum Behav. 2021; 5(7):947-953. DOI: 10.1038/s41562-021-01122-8. View

Kreps S, Prasad S, Brownstein J, Hswen Y, Garibaldi B, Zhang B . Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination. JAMA Netw Open. 2020; 3(10):e2025594. PMC: 7576409. DOI: 10.1001/jamanetworkopen.2020.25594. View

Kutasi K, Koltai J, Szabo-Morvai A, Rost G, Karsai M, Biro P . Understanding hesitancy with revealed preferences across COVID-19 vaccine types. Sci Rep. 2022; 12(1):13293. PMC: 9345393. DOI: 10.1038/s41598-022-15633-5. View

10.

Paul E, Steptoe A, Fancourt D . Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Health Eur. 2021; 1:100012. PMC: 7834475. DOI: 10.1016/j.lanepe.2020.100012. View

11.

Coppock A, Leeper T, Mullinix K . Generalizability of heterogeneous treatment effect estimates across samples. Proc Natl Acad Sci U S A. 2018; 115(49):12441-12446. PMC: 6298071. DOI: 10.1073/pnas.1808083115. View

12.

Lindholt M, Jorgensen F, Bor A, Petersen M . Public acceptance of COVID-19 vaccines: cross-national evidence on levels and individual-level predictors using observational data. BMJ Open. 2021; 11(6):e048172. PMC: 8210695. DOI: 10.1136/bmjopen-2020-048172. View

13.

Dror A, Eisenbach N, Taiber S, Morozov N, Mizrachi M, Zigron A . Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020; 35(8):775-779. PMC: 8851308. DOI: 10.1007/s10654-020-00671-y. View

14.

Sherman S, Smith L, Sim J, Amlot R, Cutts M, Dasch H . COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2020; 17(6):1612-1621. PMC: 8115754. DOI: 10.1080/21645515.2020.1846397. View

15.

Robertson E, Reeve K, Niedzwiedz C, Moore J, Blake M, Green M . Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav Immun. 2021; 94:41-50. PMC: 7946541. DOI: 10.1016/j.bbi.2021.03.008. View

16.

Yahia A, Alshahrani A, Alsulmi W, Alqarni M, Abdulrahim T, Heba W . Determinants of COVID-19 vaccine acceptance and hesitancy: a cross-sectional study in Saudi Arabia. Hum Vaccin Immunother. 2021; 17(11):4015-4020. PMC: 8828146. DOI: 10.1080/21645515.2021.1950506. View

17.

Dube E, Gagnon D, Nickels E, Jeram S, Schuster M . Mapping vaccine hesitancy--country-specific characteristics of a global phenomenon. Vaccine. 2014; 32(49):6649-54. PMC: 5355208. DOI: 10.1016/j.vaccine.2014.09.039. View

18.

Karafillakis E, Van Damme P, Hendrickx G, Larson H . COVID-19 in Europe: new challenges for addressing vaccine hesitancy. Lancet. 2022; 399(10326):699-701. PMC: 8813064. DOI: 10.1016/S0140-6736(22)00150-7. View

19.

Cooper S, van Rooyen H, Wiysonge C . COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines?. Expert Rev Vaccines. 2021; 20(8):921-933. DOI: 10.1080/14760584.2021.1949291. View

20.

Stockli S, Spalti A, Phillips J, Stoeckel F, Barnfield M, Thompson J . Which vaccine attributes foster vaccine uptake? A cross-country conjoint experiment. PLoS One. 2022; 17(5):e0266003. PMC: 9067644. DOI: 10.1371/journal.pone.0266003. View